Paxlovid that was previously authorized for emergency use in the United States is no longer approved under that authorization and must be returned to the manufacturer, according to the U.S. Food and Drug Administration (FDA). However, this change does not affect the availability of the drug for patients suffering from COVID-19 symptoms. Instead, the FDA’s […]
Read More.